Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
REGN similar filings
- 26 Apr 12 Results of Operations and Financial Condition
- 13 Feb 12 Regeneron Reports Fourth Quarter and Full Year 2011 Financial and Operating Results
- 24 Jan 12 Departure of Directors or Certain Officers
- 10 Jan 12 Regulation FD Disclosure
- 3 Jan 12 Regeneron Announces Settlement of Patent Litigation with Genentech for U.S. Ophthalmic Sales of EYLEA™ (aflibercept) Injection
- 21 Dec 11 Regulation FD Disclosure
- 5 Dec 11 Two Year Results of Phase 3 Studies with EYLEA™ (aflibercept) Injection in wet AMD Show Sustained Improvement in Visual Acuity
Filing view
External links